Real-World Experience With Tofacitinib in Steroid-Dependent Patients With Moderate-to-Severe Ulcerative Colitis on Immunomodulators
The oral small-molecule tofacitinib is an effective and safe treatment for moderate-to-severe UC that is steroid-dependent in patients already on immunomodulators.
Authors
- Sunil Dadhich (ORCID: https://orcid.org/0000-0002-8973-3408)
- Vivek Kumar Saini (ORCID: https://orcid.org/0000-0002-6898-5892)
- Bobby Mitrolia
- Abhishek Yadav (ORCID: https://orcid.org/0000-0002-1137-8389)
- Rajendra Bhati
- Narendra Bhargava
Institutions
- All India Institute of Medical Sciences Jodhpur (IN)
- Dinajpur Medical College (BD)
Publication Details
- Journal
- Cureus
- Published
- 2025-02-22
- DOI
- https://doi.org/10.7759/cureus.79456
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00